Published in Am J Pathol on August 01, 2006
Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol (2007) 1.81
Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta (2008) 1.67
From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges. Nat Med (2012) 1.34
Cell-free fetal nucleic acids in amniotic fluid. Hum Reprod Update (2010) 1.29
Placental apoptosis in health and disease. Am J Reprod Immunol (2010) 1.25
The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro. Placenta (2008) 1.13
Ascorbate prevents placental oxidative stress and enhances birth weight in hypoxic pregnancy in rats. J Physiol (2012) 0.96
Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia. Am J Pathol (2008) 0.96
Oxidative stress in preeclampsia and the role of free fetal hemoglobin. Front Physiol (2015) 0.91
Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta (2013) 0.91
Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes. J Perinatol (2014) 0.89
Tracking fetal development through molecular analysis of maternal biofluids. Biochim Biophys Acta (2012) 0.87
High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA. BMC Med Genomics (2015) 0.87
Differential effects of concomitant use of vitamins C and E on trophoblast apoptosis and autophagy between normoxia and hypoxia-reoxygenation. PLoS One (2010) 0.86
Noninvasive fetal genome sequencing: a primer. Prenat Diagn (2013) 0.85
Combined Screening for Early Detection of Pre-Eclampsia. Int J Mol Sci (2015) 0.83
Energy status and HIF signalling in chorionic villi show no evidence of hypoxic stress during human early placental development. Mol Hum Reprod (2014) 0.79
Quantification of maternal serum cell-free fetal DNA in early-onset preeclampsia. Int J Mol Sci (2013) 0.79
A1M Ameliorates Preeclampsia-Like Symptoms in Placenta and Kidney Induced by Cell-Free Fetal Hemoglobin in Rabbit. PLoS One (2015) 0.79
The Epigenome View: An Effort towards Non-Invasive Prenatal Diagnosis. Genes (Basel) (2014) 0.79
Relationships between cell-free DNA and serum analytes in the first and second trimesters of pregnancy. Obstet Gynecol (2010) 0.77
DIP-STR: highly sensitive markers for the analysis of unbalanced genomic mixtures. Hum Mutat (2013) 0.77
Cell free fetal DNA testing in maternal blood of Romanian pregnant women. Iran J Reprod Med (2015) 0.76
Distal-less 3 haploinsufficiency results in elevated placental oxidative stress and altered fetal growth kinetics in the mouse. Placenta (2012) 0.76
Trophoblast retrieval and isolation from the cervix (TRIC) is unaffected by early gestational age or maternal obesity. Prenat Diagn (2015) 0.75
Vitamin C Induces the Reduction of Oxidative Stress and Paradoxically Stimulates the Apoptotic Gene Expression in Extravillous Trophoblasts Derived From First-Trimester Tissue. Reprod Sci (2014) 0.75
Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood. Maedica (Buchar) (2015) 0.75
Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma. PLoS One (2013) 0.75
Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis. J Clin Med (2014) 0.75
Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol (1995) 9.35
Presence of fetal DNA in maternal plasma and serum. Lancet (1997) 9.01
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet (1998) 6.88
Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med (1997) 5.53
Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig (2004) 2.33
Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem (1999) 2.26
Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol (2002) 1.89
Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res (2002) 1.89
Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol (2000) 1.76
Placental apoptosis in preeclampsia. Obstet Gynecol (2000) 1.64
Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol (2003) 1.54
Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol (1997) 1.49
Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta (2004) 1.30
Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol (2004) 1.25
Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta (2003) 1.16
An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta (1981) 1.11
Fetal cells and cell free fetal nucleic acids in maternal blood: new tools to study abnormal placentation? Placenta (2004) 1.10
Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol (2004) 1.01
Placental apoptosis in normal and abnormal pregnancies. Gynecol Obstet Invest (2000) 0.88
Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA. Am J Obstet Gynecol (2005) 0.86
Serial analysis of fetal DNA concentrations in maternal plasma in late pregnancy. Clin Chem (2003) 0.83
Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythroblasts. Mol Hum Reprod (2002) 0.82
First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med (2005) 4.89
Assisted reproductive technology and pregnancy outcome. Obstet Gynecol (2005) 2.77
Transfer of fetal cells with multilineage potential to maternal tissue. JAMA (2004) 2.72
Impact of maternal age on obstetric outcome. Obstet Gynecol (2005) 2.60
Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol (2008) 2.52
Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Hum Reprod Update (2006) 2.41
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40
Intact fetal cells in maternal plasma: are they really there? Lancet (2003) 2.09
The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum (2003) 2.03
Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet (2013) 1.99
Developmental dynamics of the definitive mouse placenta assessed by stereology. Biol Reprod (2004) 1.95
Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol (2008) 1.94
Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res (2002) 1.89
Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A (2009) 1.81
Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol (2007) 1.81
Quantification of green fluorescent protein by in vivo imaging, PCR, and flow cytometry: comparison of transgenic strains and relevance for fetal cell microchimerism. Cytometry A (2008) 1.72
Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA (2011) 1.59
Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem (2013) 1.55
Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol (2003) 1.54
The importance of cysteine cathepsin proteases for placental development. J Mol Med (Berl) (2006) 1.54
Endoplasmic reticulum stress exacerbates ischemia-reperfusion-induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells. FASEB J (2006) 1.50
Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol (2004) 1.48
Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol (2007) 1.46
Morphological and biological effects of maternal exposure to tobacco smoke on the feto-placental unit. Early Hum Dev (2007) 1.45
Lessons learned from the introduction of personalized genotyping into a medical school curriculum. Genet Med (2011) 1.41
Genetic considerations in the prenatal diagnosis of overgrowth syndromes. Prenat Diagn (2009) 1.38
Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol (2005) 1.37
Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol (2006) 1.37
Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA (2005) 1.36
Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18. Hum Genet (2010) 1.32
ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta. Hum Mol Genet (2010) 1.29
Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype. Prenat Diagn (2009) 1.29
Neonatal salivary analysis reveals global developmental gene expression changes in the premature infant. Clin Chem (2009) 1.27
Early access to prenatal care: implications for racial disparity in perinatal mortality. Obstet Gynecol (2006) 1.27
Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci (2005) 1.26
Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol (2004) 1.25
Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem (2004) 1.23
The contribution of placental oxidative stress to early pregnancy failure. Hum Pathol (2003) 1.21
Cervical cancer and microchimerism. Obstet Gynecol (2003) 1.21
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo. Angiogenesis (2011) 1.20
The amniotic fluid transcriptome: a source of novel information about human fetal development. Obstet Gynecol (2012) 1.20
Reproductive issues for adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis (2008) 1.20
Fetal cells in the pregnant mouse are diverse and express a variety of progenitor and differentiated cell markers. Biol Reprod (2009) 1.20
Fetomaternal trafficking in the mouse increases as delivery approaches and is highest in the maternal lung. Biol Reprod (2008) 1.20
The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev Dyn (2006) 1.17
DFLAT: functional annotation for human development. BMC Bioinformatics (2014) 1.17
Polyol concentrations in the fluid compartments of the human conceptus during the first trimester of pregnancy: maintenance of redox potential in a low oxygen environment. J Clin Endocrinol Metab (2004) 1.15
Regulation of AKT phosphorylation at Ser473 and Thr308 by endoplasmic reticulum stress modulates substrate specificity in a severity dependent manner. PLoS One (2011) 1.15
Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioning. Am J Physiol Regul Integr Comp Physiol (2009) 1.09
Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. J Clin Invest (2007) 1.09
Maternal cell microchimerism in newborn tissues. J Pediatr (2003) 1.08
Redefining the progeroid form of Ehlers-Danlos syndrome: report of the fourth patient with B4GALT7 deficiency and review of the literature. Am J Med Genet A (2013) 1.07
High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol (2005) 1.07
Endometrial glands as a source of nutrients, growth factors and cytokines during the first trimester of human pregnancy: a morphological and immunohistochemical study. Reprod Biol Endocrinol (2004) 1.06
An obesogenic diet during mouse pregnancy modifies maternal nutrient partitioning and the fetal growth trajectory. FASEB J (2013) 1.05
Significant fetal cell microchimerism in a nontransfused woman with hepatitis C: Evidence of long-term survival and expansion. Hepatology (2002) 1.04
Evidence of endoplasmic reticulum stress and protein synthesis inhibition in the placenta of non-native women at high altitude. FASEB J (2012) 1.04
Microarray analysis of cell-free fetal DNA in amniotic fluid: a prenatal molecular karyotype. Am J Hum Genet (2004) 1.03
Fetal cell microchimerism: helpful or harmful to the parous woman? Curr Opin Obstet Gynecol (2003) 1.03
Optimal techniques for mRNA extraction from neonatal salivary supernatant. Neonatology (2011) 1.02
Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity (Silver Spring) (2012) 1.02
Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling. Cardiovasc Res (2010) 1.02
A new era in noninvasive prenatal testing. N Engl J Med (2013) 1.01
Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol (2004) 1.01
Global gene expression analysis of term amniotic fluid cell-free fetal RNA. Obstet Gynecol (2013) 1.00
The natural history of trisomy 12p. Am J Med Genet A (2006) 1.00
Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early- and late-onset pre-eclampsia. J Pathol (2014) 1.00
Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin-twin transfusion syndrome. Prenat Diagn (2013) 0.99
Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy. Clin Chem (2003) 0.99
Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress. Am J Med Genet C Semin Med Genet (2007) 0.99
Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator. Am J Pathol (2013) 0.98
Distribution and transfer pathways of antioxidant molecules inside the first trimester human gestational sac. J Clin Endocrinol Metab (2004) 0.97
Novel neurodevelopmental information revealed in amniotic fluid supernatant transcripts from fetuses with trisomies 18 and 21. Hum Genet (2012) 0.97
Comparison of extraction techniques for amniotic fluid supernatant demonstrates improved yield of cell-free fetal RNA. Prenat Diagn (2011) 0.97
Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann N Y Acad Sci (2004) 0.96
Down syndrome and cell-free fetal DNA in archived maternal serum. Am J Obstet Gynecol (2002) 0.96
Neuropeptide Y2 receptor (NPY2R) expression in saliva predicts feeding immaturity in the premature neonate. PLoS One (2012) 0.96
The role of social networking sites in medical genetics research. Am J Med Genet A (2013) 0.96
Developmental adaptations to increased fetal nutrient demand in mouse genetic models of Igf2-mediated overgrowth. FASEB J (2011) 0.95
Fetal cells in maternal tissue following pregnancy: what are the consequences? Hum Reprod Update (2004) 0.95
Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy. Fertil Steril (2004) 0.94
The contribution of birth defects to preterm birth and low birth weight. Obstet Gynecol (2007) 0.94
Endothelin-1 induces endoplasmic reticulum stress by activating the PLC-IP(3) pathway: implications for placental pathophysiology in preeclampsia. Am J Pathol (2012) 0.93
Array-CGH analysis of cell-free fetal DNA in 10 mL of amniotic fluid supernatant. Prenat Diagn (2007) 0.93
Mitochondrial dysfunction in reproduction. Mitochondrion (2004) 0.92
Fetal cell microchimerism and cancer: a nexus of reproduction, immunology, and tumor biology. Cancer Res (2011) 0.92
Obstetric outcome after early placental complications. Curr Opin Obstet Gynecol (2010) 0.91
Placental pathology in egg donor pregnancies. Fertil Steril (2009) 0.91
Larger columns and change of lysis buffer increase the yield of cell-free DNA extracted from amniotic fluid. Clin Chem (2006) 0.91
Soluble vascular endothelial growth factor receptor 1 inhibits edema and epithelial proliferation induced by 17beta-estradiol in the mouse uterus. Endocrinology (2003) 0.91
Prenatal treatment of Down syndrome: a reality? Curr Opin Obstet Gynecol (2014) 0.90
Suppression of mitochondrial electron transport chain function in the hypoxic human placenta: a role for miRNA-210 and protein synthesis inhibition. PLoS One (2013) 0.90
Noninvasive prenatal testing: the paradigm is shifting rapidly. Prenat Diagn (2013) 0.90